WALL LAB

The second aim has been leveraged by my positions in pediatrics and pathology at Harvard that provided me consistent access to clinicians and clinical data. With these interactions, my colleagues and I launched a genomic medicine initiative within Beth Israel Deaconess Medical Center that is focused on use of genomics data for clinical decision support. This effort has been funded in part through an ongoing collaboration with Affymetrix, which hopes to bring its OncoScan technology into the clinical market. We have worked on deriving clinical action from whole-genome analysis [35], construction of clinical annotation resources for use in genomic pathology for personalized healthcare [36], and on efforts to modernize pathology as nucleus for clinical genomics reporting and decision support [45,46]. Because arguably the biggest barriers to clinical genomics in healthcare is computational bottlenecks, I have focused my efforts on building new methods for genomic data processing that are..

Also known as: The Wall Lab